Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Pain × Donepezil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Radiation Injuries 4 Medulloblastoma 3 Choroid Plexus Neoplasms 3 Central Nervous System Neoplasms 3 Brain Neoplasms 3 Astrocytoma 3 Pinealoma 2 Oligodendroglioma 2 Neuroectodermal Tumors, Primitive 2 Meningioma 2 Gliosarcoma 2 Glioma, Subependymal 2 Glioma 2 Glioblastoma 2 Fatigue 2 Ependymoma 2 Depression 2 Craniopharyngioma 2 Cognitive Dysfunction 2 Breast Neoplasms 2 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Sleep Wake Disorders 1 Optic Nerve Glioma 1 Neurotoxicity Syndromes 1 Neoplasm Metastasis 1 Memory Disorders 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Familial ependymoma 1

Interventions

Morphine 15 Oxycodone 12 Methadone 7 Fentanyl 6 Lidocaine 5 Acetaminophen 5 nabiximols 4 Ethanol 4 resiniferatoxin 3 Transcutaneous Electric Nerve Stimulation 3 Hydromorphone 3 Buprenorphine 3 Acupuncture Therapy 3 Tapentadol 2 Surveys and Questionnaires 2 Standard of Care 2 Sodium Bicarbonate 2 Radiofrequency Ablation 2 Pharmaceutical Services 2 Ketamine 2 Control Groups 2 Analgesics, Opioid 2 tanezumab 1 rofecoxib 1 oxycodone naloxone combination 1 naloxegol 1 incobotulinumtoxinA 1 fulranumab 1 cannabichromene 1 Water 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00352664 2016-05-09

The Effect of Donepezil on Sedation and Other Symptoms

M.D. Anderson Cancer Center

Phase 3 Terminated

27 enrolled 2 charts

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡